Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664248 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
A Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,414
- Enrollment target
NCT00664248: Completed Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
NCT00664248 is a Phase 3 study that has completed, run by Dow Pharmaceutical Sciences. The registered enrollment target is 1,414 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (83% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00664248, a Phase 3 study, has completed, sponsored by Dow Pharmaceutical Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,414 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Interventions
- DRUG Clindamycin
- DRUG Vehicle
- DRUG Benzoyl peroxide
- DRUG IDP-110
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,414 participants |
| Start Date | 2006-10 |
| Phase | Phase 3 |
What the finished NCT00664248 record still lists
NCT00664248 is an interventional study that assigns participants to a tested intervention. Its 1,414 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (83% higher).
The record links to 0 conditions, and to 4 interventions - of which Clindamycin is the first listed.
NCT00664248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00664248 about?
NCT00664248 is a clinical study titled "A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris". The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
What is the current status of trial NCT00664248?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,414 participants. The study started on 2006-10.
What interventions are being tested in trial NCT00664248?
The interventions under investigation include: Clindamycin (DRUG), Vehicle (DRUG), Benzoyl peroxide (DRUG), IDP-110 (DRUG).
Who is sponsoring clinical trial NCT00664248?
This trial is sponsored by Dow Pharmaceutical Sciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00664248's enrollment target sits among peer trials
1,414 170th of 2000 higher than 1,831 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia